Additionally, higher levels of Gal-3 have been observed in T2DM patients compared to non-diabetic individuals [112], placing Gal-3 as a viable tool for detecting the initial stages of cardiomyopathy in T2DM patients. The gene discussed is LGALS3; the disease is cardiomyopathy.